Fig. 1From: Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemicStudy flow diagram. Out of 48,066 patients screened, we included 9,681 patients in our analysis. Among these patients, 9,325 were included in the control group and 329 were included in the anticoagulation groupBack to article page